Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

New proposal developed by HIQA for research ethics in Ireland

By Mindo - 14th May 2018 | 27 views

To achieve this, the Authority has recommended that a review of the Health Information and Patient Safety (HIPS) Bill be considered in relation to research ethics committees (RECs).

HIQA is expected to take the role of supervisory body of RECs in relation to clinical trials of investigational products (CTIMPs) as required by new EU regulations and under the Health Information and Patient Safety (HIPS) Bill.

According to a letter from HIQA CEO Mr Phelim Quinn, sent to Secretary General of the Department of Health Mr Jim Breslin, seen by <strong><em>MI</em></strong> through Freedom of Information legislation, consideration should be given to expanding the proposed new national committee for CTIMPs to include a remit for multi-site ‘other’ human health research, instead of the structure of several institution-based committees.

It is proposed that the new national committee will have four panels, with each panel meeting regularly to allow for compliance with the tight timelines in the new EU regulation.

“Although more information is needed, at this time HIQA is of the opinion that the new national ethics committee could also be expanded appropriately to manage clinical investigations of medical devices and research proposals involving ionising radiation,” according to Mr Quinn.

“There would be many advantages to having one such system, with many of the stakeholders being involved across all research fields. It would ensure as much consistency to the entire system as possible, and if organised and managed appropriately, should improve the area of human health research for all in Ireland and significantly increase the amount of research conducted here.”

In his letter, Mr Quinn points out that HIQA has so far been working with two separate groups within the Department on the two main pieces of legislation: The Medicine Unit in relation to CTIMPs, and the International and Research and Policy Division in relation to the HIPS Bill. “At this time, there are two very different models proposed for the organisation of the research ethics committees involved, and two likely very different roles for HIQA as the supervisory body of those RECs,” according to the letter.

Part 3 of the General Scheme of the HIPS Bill, published in November 2015, outlined a model involving institution-based RECs, which may or may not apply to HIQA for approval.

A significant aspect of this part of the Bill is the provision for a “single opinion”, ie, a mechanism for researchers proposing to undertake multi-site research to apply to an approved REC, which will be able to provide a decision that will be valid for the State, or part of the State.

The current situation is that researchers have to apply to the REC of each site involved in multi-site research proposals, which is a very complicated and lengthy process.

The Oireachtas Health Committee has published a report of its pre-legislation scrutiny of the Bill, and it raises a recommendation and many issues with the research ethics section.

Mr Quinn said expanding the proposed national committee for CTIMPS would ensure that the main key benefit of Part 3 of the Bill (the ‘single opinion’) would be covered by the new national committee, while the new model could also potentially solve many issues listed in the Oireachtas Health Committee’s report.

Speaking to <strong><em>MI</em></strong>, Mr Quinn said that the Department of Health has responded positively to the proposals.

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read